DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $411,000 | +10.5% | 17,716 | 0.0% | 0.00% | – |
| Q4 2018 | $372,000 | -68.3% | 17,716 | -41.5% | 0.00% | – |
| Q3 2018 | $1,172,000 | +88.1% | 30,278 | +91.1% | 0.00% | – |
| Q2 2018 | $623,000 | +126.5% | 15,842 | +15.6% | 0.00% | – |
| Q1 2018 | $275,000 | +7.0% | 13,708 | +20.7% | 0.00% | – |
| Q4 2017 | $257,000 | – | 11,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |